What is WGS's gross margin?

GeneDx (WGS) has a gross margin of 68% and a net margin of -16%.

What is WGS's P/E ratio?

Track GeneDx (WGS) P/E ratio, ROE, and valuation metrics over time.

Where can I see WGS's full financials?

See GeneDx (WGS) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

GeneDx (WGS) Financials — Revenue, Earnings, Cash Flow

Also trades as: WGSWW (NASDAQ) · $vol 0M

$73.09

+2.13 (+3.00%)

Weekly Expected Move ±10.7%

$57 $65 $73 $81 $89

NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 37 · $2.2B mcap · 28M float · 3.05% daily turnover · Short 61% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$454M

Revenue

+25.4% YoY

$-106M

Net Income

-7664.5% YoY

$-76M

Free Cash Flow

-9232.3% YoY

68.4%

Gross Margin

-15.3%

Op. Margin

-15.5%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-40.8%

ROA-22.5%

ROIC-17.2%

Valuation

P/E-20.1

P/B8.9

EV/EBITDA-27.1

Leverage

Debt/Equity0.69

Current Ratio3.30

Interest Cov.-34.6x

Quality Scores

Piotroski F4/9

Altman Z1.59

Beneish M-2.59